Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol soft capsule in CKD secondary hyperparathyroidism (Phase III, China)
CTR20211369Phase 3Completed
- Sponsor
- Chengdu Shengdi
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paricalcitol in secondary hyperparathyroidism (SHPT), sponsored by Chengdu Shengdi. Started Jul 2021; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on CTR20211369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211369.